MedTrace Logo

Investigation and Detection of Urological Neoplasia in Patients Referred With Suspected Urinary Tract Cancer:

NCT03548688 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11059

Last updated 2021-11-11

No results posted yet for this study

Summary

Bladder cancer is common in the UK and can kill. A common sign of bladder cancer is blood in the urine (haematuria).

GPs will refer to a specialist (Urologist) for further investigation of haematuria if they suspect cancer.

Hospitals often have a 'blanket' approach for investigating patients with haematuria. IDENTIFY will collect data on patients having these tests across the UK and internationally, looking at any trends with an aim to create a personalised diagnostic approach for each patient. The data will give patients the ability to make informed decisions, as well as reducing unnecessary and potentially harmful tests.

Conditions

Sponsors & Collaborators

  • The Urology Foundation

    collaborator UNKNOWN

  • Action Bladder Cancer UK

    collaborator OTHER

  • Test Evaluation Research Group Birmingham University

    collaborator UNKNOWN

  • British Urology Researchers in Surgical Training

    lead OTHER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-14
Primary Completion
2019-12-14
Completion
2020-01-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03548688 on ClinicalTrials.gov